Volara Class I Recall Update: What to check (July 14, 2026)

Before the next Volara System breathing therapy session at home, pause and do two quick checks. The FDA’s updated Class I correction explains a potential safety issue involving air and medication leakage from the nebulizer cup when the cup isn’t properly locked during setup after medication is added.

The goal is practical: confirm whether your circuits are affected, inspect the nebulizer cup and locking step before each session, and stop using the circuit and replace it if you see leakage.

Quick context (FDA update, July 14, 2026): FDA issued/updated public safety instructions for certain Baxter Volara System patient circuits. The concern is leakage that can happen during therapy when the nebulizer cup is not securely locked after medication is added. FDA’s recommended actions focus on checking affected units and replacing the patient circuit if leakage is observed.

What’s the problem, in plain language?

According to the FDA, Volara System single-patient-use circuits may experience air and medication leakage from the nebulizer cup during therapy if the nebulizer cup is not fully and securely locked during assembly after medication is added.

The FDA warns that leakage can lead to:

Ineffective nebulization (the prescribed therapy may not be delivered as intended).
Oxygenation problems, including desaturation and serious respiratory worsening—this is especially important for pediatric home-care users.
Potentially serious adverse outcomes if the patient’s breathing or oxygen levels worsen while home therapy is in use.

Why this matters at home

Home respiratory therapy depends on correct device setup and close attention during treatment. If a circuit leaks, the patient may receive less effective therapy and oxygenation may be affected. For children receiving therapy at home, the margin for error is smaller—so caregivers should follow the FDA’s setup and “what to do if you see leakage” steps.

What readers can do: a step-by-step checklist

Step 1: Confirm whether your circuits are included

Check the FDA’s CDRH Medical Device Recall Database entry for this action (Recall record ID 220865):

Match your product/unit details (such as product description/product code/model information and any identifiers shown in your shipment materials or on the device packaging) to what FDA lists in the recall entry.
If you can’t confirm coverage, gather the details you have (including lot/serial information if available) and contact your home care team or the manufacturer/clinic support for help.

Step 2: Before each home therapy session, inspect and lock correctly

The FDA’s recommended approach is to make the setup step consistent every time:

Inspect the nebulizer cup for damage before each use.
Ensure the nebulizer cup is fully and securely locked during assembly, following the device’s instructions—especially after medication is added.

Step 3: If you see leakage, stop and replace

If leakage is observed during therapy, the FDA instructs users to:

Discontinue use of the affected circuit/nebulizer setup.
Replace the patient circuit.
Contact your healthcare provider/care team if leakage persists or you are unsure how to continue therapy safely.

Caregiver infection-prevention reminder

Alongside FDA device steps, use safe patient-care habits. The CDC’s Standard Precautions emphasize practical infection-prevention behaviors around patient care equipment, such as:

Hand hygiene
Using appropriate PPE when exposure to body fluids is possible
Proper handling, cleaning, and disinfection of patient care equipment

Always follow your clinician’s instructions for cleaning and reprocessing. If you suspect an assembly/locking problem that could cause leakage, prioritize the FDA’s “replace the circuit” step before continuing therapy.

When to get urgent help

If breathing or oxygenation seems to worsen while home therapy is running, treat it as urgent. The FDA links circuit leakage to reduced oxygenation and serious respiratory worsening. Pediatric home-care families can also use “watch closely” guidance (breathing, color, activity) and know that delayed or missed alarms can happen.

Next step: Contact your care team promptly if you notice concerning respiratory changes during therapy. If the patient has severe breathing difficulty, is rapidly worsening, or you cannot reach the care team, seek emergency care.

What’s known vs. not yet known

Known: FDA describes a mechanism involving air/medication leakage that can occur when the nebulizer cup is not properly locked after medication is added. Leakage may contribute to ineffective nebulization and oxygenation problems, with heightened concern for pediatric home-care users.
Known (safety communication): FDA’s instructions focus on identifying affected circuits, inspecting and locking correctly, and replacing the patient circuit if leakage is observed.
Not yet known: FDA communications do not provide an easy-to-use estimate of how often leakage occurs in everyday home use or how outcomes vary across different patients and situations.

The practical takeaway

Check the FDA recall database record for ID 220865 to see if your circuits are included. Then, before each session, inspect the nebulizer cup and make sure it’s locked securely during assembly. If you see leakage, stop and replace the circuit and contact your care team if you’re unsure—especially for children receiving home therapy.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.